Tissue expression of IL-17A and FOXP3 in acne vulgaris patients.
Azza Gaber Antar FaragAlaa Hassan MaraeeDalia Rifaat Al-SharakyMustafa Elsayed ElshaibMarwa Samir Mohamed KohlaWafaa Ahmed ShehataPublished in: Journal of cosmetic dermatology (2020)
There was an up-regulation of IL-17A and FOXP3 in acne vulgaris development, but with independent roles. Moreover, targeting of IL-17A and FOXP3 may open the door for development of new therapeutic agents in acne vulgaris treatment.